Effect of Lissachatina fulica chitosan on the antioxidant and lipid profile of hypercholesterolemic male Wistar rats
Context: The increase in reactive oxygen species production in hypercholesterolemia can degrade polyunsaturated fatty acids and form malondialdehyde (MDA). There is a need for a natural alternative treatment, such as Lissachatina fulica chitosan. Aims: To analyze the potential of Lissachatina fulica...
Saved in:
Main Authors: | , , , |
---|---|
Format: | Book |
Published: |
GarVal Editorial Ltda.,
2022-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
MARC
LEADER | 00000 am a22000003u 4500 | ||
---|---|---|---|
001 | doaj_e99100e58db64dda9f578b8c3d19a9c7 | ||
042 | |a dc | ||
100 | 1 | 0 | |a Umarudin |e author |
700 | 1 | 0 | |a Sri Widyarti |e author |
700 | 1 | 0 | |a Warsito |e author |
700 | 1 | 0 | |a Sri Rahayu |e author |
245 | 0 | 0 | |a Effect of Lissachatina fulica chitosan on the antioxidant and lipid profile of hypercholesterolemic male Wistar rats |
260 | |b GarVal Editorial Ltda., |c 2022-11-01T00:00:00Z. | ||
500 | |a https://doi.org/10.56499/jppres22.1468_10.6.995 | ||
500 | |a 0719-4250 | ||
520 | |a Context: The increase in reactive oxygen species production in hypercholesterolemia can degrade polyunsaturated fatty acids and form malondialdehyde (MDA). There is a need for a natural alternative treatment, such as Lissachatina fulica chitosan. Aims: To analyze the potential of Lissachatina fulica chitosan in increasing the superoxide dismutase (SOD) level, reducing lipid profile, and MDA level of male Wistar rats with hypercholesterolemia model. Methods: The male Wistar rats were divided into six groups (n = 4): P0 (normal control); P1-P5 fed a high-fat diet for four weeks. P1 were treated with fed with a high-fat diet; P2 were treated with ezetimibe of 0.18 mg/200 g BW; P3, P4, and P5 Groups; fed with a high-fat diet and Lissachatina fulica chitosan of 100 mg, 200 mg, and 300 mg/200g BW, respectively. The lipid profile was conducted in rat blood samples by using the CHOP-PAP method, the MDA analysis using the TBARS test, and SOD assay analysis using a kit. Results: The results reveal that the treatment Lissachatina fulica chitosan (300 mg/200 g BW) was significantly effective (p<0.05) to decrease in total cholesterol level (96.7 ± 1.9 mg/dL), triglyceride (75.6 ± 1.6 mg/dL), LDL (29.8 ± 2.5 mg/dL), and MDA (1.2 ± 0.1 nmol/mL) as well as a significant increase (p<0.05) in HDL level (75.0 ± 1.7 mg/dL) and SOD (74.6 ± 2.1 unit/mL). Conclusions: Lissachatina fulica chitosan can reduce total cholesterol, triglyceride, LDL, and MDA, and increase HDL and SOD levels. | ||
546 | |a EN | ||
546 | |a ES | ||
690 | |a hypercholesterolemia | ||
690 | |a lipid profile | ||
690 | |a lissachatina fulica chitosan | ||
690 | |a mda | ||
690 | |a sod | ||
690 | |a Therapeutics. Pharmacology | ||
690 | |a RM1-950 | ||
690 | |a Pharmacy and materia medica | ||
690 | |a RS1-441 | ||
655 | 7 | |a article |2 local | |
786 | 0 | |n Journal of Pharmacy & Pharmacognosy Research, Vol 10, Iss 6, Pp 995-1005 (2022) | |
787 | 0 | |n https://jppres.com/jppres/pdf/vol10/jppres22.1468_10.6.995.pdf | |
787 | 0 | |n https://doaj.org/toc/0719-4250 | |
856 | 4 | 1 | |u https://doaj.org/article/e99100e58db64dda9f578b8c3d19a9c7 |z Connect to this object online. |